Our Pipeline
We advance antibody science in areas with the greatest human impact.
Product
Target
Discovery
Candidate Validation
PoC Efficacy
IND-Enabling
OB-24-01
RSV
Status
OB-24-02
ActRIIA/B -Human Metabolism
STATUS
OB-25-01
Undisclosed – Orphan Drug
STATUS
OB-25-02
Undisclosed Oncology ADC
STATUS
Product
OB-24-01
Target
RSV
STATUS
POC EFFICACY
Product
OB-24-02
Target
ActRIIA/B -Human Metabolism
STATUS
CANDIDATE VALIDATION
Product
OB-24-01
Target
Undisclosed – Orphan Drug
STATUS
DISCOVERY
Product
OB-24-01
Target
Undisclosed Oncology ADC
STATUS
DISCOVERY
With a mission to improve patient health and quality of life, OCMS Bio’s pipeline is built to resolve issues with efficacy, safety and dose frequency and size that current therapies are plagued with. That is why the OCMS team is committed to bring the best possible drugs to the patient, as quickly as possible.